CorrespondencePregnancy-related fibroid reduction
Key Words
Cited by (0)
S.K.L. has nothing to disclose. A.H.H. has nothing to disclose. D.A.S. has nothing to disclose. A.F.O. has nothing to disclose. J.R.F. has nothing to disclose. K.E.H. has nothing to disclose. D.D.B. has nothing to disclose.
The work was conducted as part of the Right from the Start study. The parent study received support from the American Water Works Association Research Foundation under contract no. 2579 (D.A.S.); Pfizer Scholars Grants for Faculty Development in Clinical Epidemiology (K.E.H.), and National Institute of Child Health and Human Development Grants RO1 HD043883-04 and HD049675: “Consequences and Course of Uterine Fibroids in Pregnancy” (K.E.H.). S.K.L. was supported by the National Institutes of Health (NIH) Women's Health Fellowships in Intramural Women's Health Research. The postpartum data collection research was supported in part by the Intramural Research Program of the NIH and the National Institute of Environmental Health Sciences (P30ES10126).